Utah Medical Products Inc (UTMD) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Utah Medical Products Inc stock (UTMD) is currently trading at $63.71. Utah Medical Products Inc PE ratio is 18.60. Utah Medical Products Inc PS ratio (Price-to-Sales) is 5.31. WallStSmart rates UTMD as Underperform.
- UTMD PE ratio analysis and historical PE chart
- UTMD PS ratio (Price-to-Sales) history and trend
- UTMD intrinsic value — DCF, Graham Number, EPV models
- UTMD stock price prediction 2025 2026 2027 2028 2029 2030
- UTMD fair value vs current price
- UTMD insider transactions and insider buying
- Is UTMD undervalued or overvalued?
- Utah Medical Products Inc financial analysis — revenue, earnings, cash flow
- UTMD Piotroski F-Score and Altman Z-Score
- UTMD analyst price target and Smart Rating
Utah Medical Products Inc
📊 No data available
Try selecting a different time range
UTMD Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Utah Medical Products Inc (UTMD)
UTMD trades 173% above its Graham fair value of $23.32, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Utah Medical Products Inc (UTMD) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in operating margin, price/book, profit margin. Concerns around market cap and peg ratio. Mixed signals suggest waiting for clearer direction before acting.
Utah Medical Products Inc (UTMD) Key Strengths (4)
Keeps $31 of every $100 in revenue after operating costs
Keeps $29 of every $100 in revenue as net profit
Trading at 1.70x book value, attractively priced
69.61% held by institutions, strong professional interest
Supporting Valuation Data
Utah Medical Products Inc (UTMD) Areas to Watch (6)
Revenue declining -1.20%, a shrinking business
Earnings declining -6.40%, profits shrinking
Very expensive relative to growth, significant premium
Micro-cap company with very limited liquidity and high volatility
Low profitability relative to shareholder equity
Premium valuation at 5.3x annual revenue
Supporting Valuation Data
Utah Medical Products Inc (UTMD) Detailed Analysis Report
Overall Assessment
This company scores 48/100 in our Smart Analysis, earning a D+ grade. Out of 10 metrics analyzed, 4 register as strengths (avg 9.0/10) while 6 fall into concern territory (avg 2.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Operating Margin, Profit Margin, Price/Book. Valuation metrics including Price/Book (1.70) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 31.10%, Profit Margin at 29.30%.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, PEG Ratio. Some valuation metrics including PEG Ratio (4.25), Price/Sales (5.31) suggest expensive pricing. Growth concerns include Revenue Growth at -1.20%, EPS Growth at -6.40%, which may limit upside. Profitability pressure is visible in Return on Equity at 9.54%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 9.54% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -1.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Revenue Growth and EPS Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
UTMD Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
UTMD's Price-to-Sales ratio of 5.31x trades at a 26% premium to its historical average of 4.22x (81th percentile). The current valuation is 37% below its historical high of 8.47x set in Jun 2018, and 121% above its historical low of 2.4x in Dec 2008.
Compare UTMD with Competitors
Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Utah Medical Products Inc (UTMD) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Utah Medical Products Inc faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 39M with 1% decline year-over-year. Profit margins are strong at 29.3%, reflecting pricing power and operational efficiency.
Key Findings
Profit margin of 29.3% and operating margin of 31.1% demonstrate strong pricing power and operational efficiency.
What to Watch Next
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Utah Medical Products Inc.
Bottom Line
Utah Medical Products Inc faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Utah Medical Products Inc(UTMD)
NASDAQ
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The company is headquartered in Midvale, Utah.